The addition of an IL-17 neutralizing antibody, partially reversed the impact of the obese MAIT cell secretome, highlighting IL-17 as a causative factor, and further supporting the concept of MAIT cells as a pathogenic player in obesity and the development of metabolic diseases such as type 2 diabetes mellitus. This evidence concerns the gene IL17A and Other metabolic disease.